PRTK Annual Net Income
-$63.57 M
-$4.48 M-7.59%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual net profit is -$63.57 million, with the most recent change of -$4.48 million (-7.59%) on December 31, 2022. During the last 3 years, it has risen by +$65.22 million (+50.64%).PRTK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Net Income
-$14.55 M
+$5.59 M+27.75%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly net profit is -$14.55 million, with the most recent change of +$5.59 million (+27.75%) on June 30, 2023. Over the past year, it has increased by +$3.07 million (+17.40%).PRTK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM Net Income
-$62.73 M
+$3.07 M+4.66%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM net profit is -$62.73 million, with the most recent change of +$3.07 million (+4.66%) on June 30, 2023. Over the past year, it has increased by +$23.25 million (+27.04%).PRTK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.6% | +17.4% | +27.0% |
| 3 y3 years | +50.6% | +36.9% | +43.3% |
| 5 y5 years | +28.6% | +51.0% | +51.3% |
PRTK Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +3920.6% | -130.9% | -256.5% |
Paratek Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$14.55 M(-27.8%) | -$62.73 M(-4.7%) |
| Mar 2023 | - | -$20.14 M(+181.4%) | -$65.80 M(+3.5%) |
| Dec 2022 | -$63.57 M(+7.6%) | -$7.16 M(-65.7%) | -$63.57 M(-28.3%) |
| Sept 2022 | - | -$20.88 M(+18.5%) | -$88.66 M(+3.1%) |
| June 2022 | - | -$17.62 M(-1.6%) | -$85.98 M(+46.6%) |
| Mar 2022 | - | -$17.91 M(-44.5%) | -$58.65 M(-0.7%) |
| Dec 2021 | -$59.08 M(-38.8%) | -$32.25 M(+77.2%) | -$59.08 M(+14.0%) |
| Sept 2021 | - | -$18.20 M(-287.3%) | -$51.84 M(-4.9%) |
| June 2021 | - | $9.72 M(-153.0%) | -$54.49 M(-37.6%) |
| Mar 2021 | - | -$18.35 M(-26.6%) | -$87.27 M(-9.6%) |
| Dec 2020 | -$96.54 M(-25.0%) | -$25.01 M(+19.9%) | -$96.54 M(-2.4%) |
| Sept 2020 | - | -$20.86 M(-9.6%) | -$98.90 M(-10.6%) |
| June 2020 | - | -$23.06 M(-16.5%) | -$110.66 M(-8.4%) |
| Mar 2020 | - | -$27.62 M(+0.9%) | -$120.80 M(-6.2%) |
| Dec 2019 | -$128.79 M(+14.6%) | -$27.36 M(-16.1%) | -$128.79 M(+3.7%) |
| Sept 2019 | - | -$32.61 M(-1.8%) | -$124.22 M(+0.4%) |
| June 2019 | - | -$33.20 M(-6.8%) | -$123.69 M(+2.9%) |
| Mar 2019 | - | -$35.61 M(+56.2%) | -$120.22 M(+7.0%) |
| Dec 2018 | -$112.36 M(+26.1%) | -$22.79 M(-29.0%) | -$112.36 M(+0.8%) |
| Sept 2018 | - | -$32.08 M(+7.9%) | -$111.46 M(+10.7%) |
| June 2018 | - | -$29.73 M(+7.1%) | -$100.70 M(+13.0%) |
| Mar 2018 | - | -$27.75 M(+26.8%) | -$89.15 M(+0.1%) |
| Dec 2017 | -$89.07 M(-20.2%) | -$21.89 M(+2.7%) | -$89.07 M(-4.9%) |
| Sept 2017 | - | -$21.32 M(+17.3%) | -$93.63 M(-2.4%) |
| June 2017 | - | -$18.18 M(-34.3%) | -$95.94 M(-11.2%) |
| Mar 2017 | - | -$27.67 M(+4.6%) | -$108.03 M(-3.2%) |
| Dec 2016 | -$111.64 M(+57.5%) | -$26.45 M(+12.0%) | -$111.64 M(+5.0%) |
| Sept 2016 | - | -$23.63 M(-22.0%) | -$106.29 M(+0.2%) |
| June 2016 | - | -$30.28 M(-3.2%) | -$106.08 M(+15.9%) |
| Mar 2016 | - | -$31.27 M(+48.2%) | -$91.50 M(+29.1%) |
| Dec 2015 | -$70.86 M(+297.3%) | -$21.11 M(-9.9%) | -$70.86 M(+33.1%) |
| Sept 2015 | - | -$23.42 M(+49.2%) | -$53.26 M(+40.0%) |
| June 2015 | - | -$15.70 M(+47.6%) | -$38.04 M(+48.2%) |
| Mar 2015 | - | -$10.63 M(+203.5%) | -$25.66 M(+43.9%) |
| Dec 2014 | -$17.84 M(-35.0%) | -$3.50 M(-57.3%) | -$17.84 M(-10.2%) |
| Sept 2014 | - | -$8.20 M(+146.6%) | -$19.87 M(+21.4%) |
| June 2014 | - | -$3.33 M(+18.6%) | -$16.37 M(-17.1%) |
| Mar 2014 | - | -$2.80 M(-49.3%) | -$19.75 M(-28.0%) |
| Dec 2013 | -$27.45 M | -$5.54 M(+17.7%) | -$27.45 M(-3.6%) |
| Sept 2013 | - | -$4.70 M(-29.9%) | -$28.46 M(+50.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$6.71 M(-36.1%) | -$18.91 M(+9.0%) |
| Mar 2013 | - | -$10.50 M(+60.2%) | -$17.34 M(+44.3%) |
| Dec 2012 | -$12.02 M(+209.7%) | -$6.55 M(-235.0%) | -$12.02 M(+7138.6%) |
| Sept 2012 | - | $4.86 M(-194.5%) | -$166.00 K(-98.3%) |
| June 2012 | - | -$5.14 M(-0.7%) | -$10.01 M(+40.7%) |
| Mar 2012 | - | -$5.18 M(-197.8%) | -$7.12 M(+83.5%) |
| Dec 2011 | -$3.88 M(-58.3%) | $5.30 M(-206.1%) | -$3.88 M(-67.1%) |
| Sept 2011 | - | -$4.99 M(+122.2%) | -$11.81 M(+23.2%) |
| June 2011 | - | -$2.25 M(+15.8%) | -$9.59 M(+2.0%) |
| Mar 2011 | - | -$1.94 M(-26.4%) | -$9.40 M(+1.0%) |
| Dec 2010 | -$9.30 M(-57.3%) | -$2.63 M(-4.8%) | -$9.30 M(+3.2%) |
| Sept 2010 | - | -$2.77 M(+34.3%) | -$9.01 M(-10.3%) |
| June 2010 | - | -$2.06 M(+11.9%) | -$10.05 M(-33.4%) |
| Mar 2010 | - | -$1.84 M(-21.4%) | -$15.10 M(-30.7%) |
| Dec 2009 | -$21.80 M(+9.2%) | -$2.34 M(-38.4%) | -$21.80 M(-72.2%) |
| Sept 2009 | - | -$3.81 M(-46.5%) | -$78.48 M(-3.8%) |
| June 2009 | - | -$7.11 M(-16.7%) | -$81.56 M(+198.4%) |
| Mar 2009 | - | -$8.54 M(-85.5%) | -$27.34 M(+37.0%) |
| Dec 2008 | -$19.96 M(-38.6%) | -$59.03 M(+757.9%) | -$19.96 M(-154.8%) |
| Sept 2008 | - | -$6.88 M(-114.6%) | $36.44 M(-9.1%) |
| June 2008 | - | $47.11 M(-4161.4%) | $40.09 M(-273.9%) |
| Mar 2008 | - | -$1.16 M(-55.9%) | -$23.05 M(-29.1%) |
| Dec 2007 | -$32.53 M(+9.8%) | -$2.63 M(-18.8%) | -$32.53 M(-13.8%) |
| Sept 2007 | - | -$3.24 M(-79.8%) | -$37.72 M(-8.9%) |
| June 2007 | - | -$16.03 M(+50.6%) | -$41.42 M(+26.3%) |
| Mar 2007 | - | -$10.64 M(+36.1%) | -$32.79 M(+10.7%) |
| Dec 2006 | -$29.63 M(+24.5%) | -$7.82 M(+12.6%) | -$29.63 M(+6.7%) |
| Sept 2006 | - | -$6.94 M(-6.2%) | -$27.76 M(+3.7%) |
| June 2006 | - | -$7.40 M(-1.0%) | -$26.77 M(+99.4%) |
| Mar 2006 | - | -$7.47 M(+25.6%) | -$13.42 M(+12.8%) |
| Dec 2005 | -$23.80 M(+32.6%) | -$5.95 M(0.0%) | -$11.90 M(+14.0%) |
| Sept 2005 | - | -$5.95 M(-200.0%) | -$10.44 M(+16.3%) |
| June 2005 | - | $5.95 M(-200.0%) | -$8.98 M(-53.8%) |
| Mar 2005 | - | -$5.95 M(+32.6%) | -$19.41 M(+8.1%) |
| Dec 2004 | -$17.95 M(+40.5%) | -$4.49 M(0.0%) | -$17.95 M(+33.3%) |
| Sept 2004 | - | -$4.49 M(0.0%) | -$13.46 M(+50.0%) |
| June 2004 | - | -$4.49 M(0.0%) | -$8.98 M(+100.0%) |
| Mar 2004 | - | -$4.49 M | -$4.49 M |
| Dec 2003 | -$12.78 M(+126.7%) | - | - |
| Dec 2002 | -$5.64 M(+256.5%) | - | - |
| Dec 2001 | -$1.58 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual net profit?
- What is the all time high annual net income for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual net income year-on-year change?
- What is Paratek Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly net income year-on-year change?
- What is Paratek Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM net income year-on-year change?
What is Paratek Pharmaceuticals annual net profit?
The current annual net income of PRTK is -$63.57 M
What is the all time high annual net income for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual net profit is -$1.58 M
What is Paratek Pharmaceuticals annual net income year-on-year change?
Over the past year, PRTK annual net profit has changed by -$4.48 M (-7.59%)
What is Paratek Pharmaceuticals quarterly net profit?
The current quarterly net income of PRTK is -$14.55 M
What is the all time high quarterly net income for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly net profit is $47.11 M
What is Paratek Pharmaceuticals quarterly net income year-on-year change?
Over the past year, PRTK quarterly net profit has changed by +$3.07 M (+17.40%)
What is Paratek Pharmaceuticals TTM net profit?
The current TTM net income of PRTK is -$62.73 M
What is the all time high TTM net income for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM net profit is $40.09 M
What is Paratek Pharmaceuticals TTM net income year-on-year change?
Over the past year, PRTK TTM net profit has changed by +$23.25 M (+27.04%)